For patients infected with hepatitis C virus (HCV), loss to follow-up (LTF) exceeds the viral failure rate among those who initiate direct-acting antiviral (DAA) therapy, according to a study published in the Journal of Viral Hepatitis. The investigators found that rates of LTF varied significantly based on HCV genotype (GT), treatment regimen, and most notably…
Hannah Dellabella
Contributing Writer
Hannah Dellabella is a freelance writer for Haymarket Media. She holds an MFA in creative writing from Purdue University and a BA in creative writing and professional writing from Carnegie Mellon University. Previously, she was the associate editor for Clinical Advisor at Haymarket Media and an assistant editor for the Haymarket Medical Network. In addition to being a medical writer, Hannah is a poet whose work has appeared in various literary journals.
